Non-coding RNA networks in cancer

被引:1512
作者
Anastasiadou, Eleni [1 ]
Jacob, Leni S. [1 ]
Slack, Frank J. [1 ]
机构
[1] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Pathol, Initiat RNA Med, Boston, MA 02215 USA
基金
美国国家卫生研究院;
关键词
CELL LUNG-CANCER; TUMOR-SUPPRESSOR; CIRCULAR RNA; IN-VIVO; MICRORNA-TARGET; 3' UTR; ALTERNATIVE CLEAVAGE; ENDOGENOUS MICRORNA; CERNA HYPOTHESIS; PROSTATE-CANCER;
D O I
10.1038/nrc.2017.99
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Thousands of unique non-coding RNA (ncRNA) sequences exist within cells. Work from the past decade has altered our perception of ncRNAs from 'junk' transcriptional products to functional regulatory molecules that mediate cellular processes including chromatin remodelling, transcription, post-transcriptional modifications and signal transduction. The networks in which ncRNAs engage can influence numerous molecular targets to drive specific cell biological responses and fates. Consequently, ncRNAs act as key regulators of physiological programmes in developmental and disease contexts. Particularly relevant in cancer, ncRNAs have been identified as oncogenic drivers and tumour suppressors in every major cancer type. Thus, a deeper understanding of the complex networks of interactions that ncRNAs coordinate would provide a unique opportunity to design better therapeutic interventions.
引用
收藏
页码:5 / 18
页数:14
相关论文
共 162 条
  • [1] Alberts B., 2002, MOL BIOL CELL, V4th
  • [2] Network motifs: theory and experimental approaches
    Alon, Uri
    [J]. NATURE REVIEWS GENETICS, 2007, 8 (06) : 450 - 461
  • [3] Anadón C, 2016, ONCOGENE, V35, P4407, DOI 10.1038/onc.2015.469
  • [4] Epstein-Barr virus encoded LMP1 downregulates TCL1 oncogene through miR-29b
    Anastasiadou, E.
    Boccellato, F.
    Vincenti, S.
    Rosato, P.
    Bozzoni, I.
    Frati, L.
    Faggioni, A.
    Presutti, C.
    Trivedi, P.
    [J]. ONCOGENE, 2010, 29 (09) : 1316 - 1328
  • [6] [Anonymous], NATURE
  • [7] Long Noncoding RNA TARID Directs Demethylation and Activation of the Tumor Suppressor TCF21 via GADD45A
    Arab, Khelifa
    Park, Yoon Jung
    Lindroth, Anders M.
    Schaefer, Andrea
    Oakes, Christopher
    Weichenhan, Dieter
    Lukanova, Annekatrin
    Lundin, Eva
    Risch, Angela
    Meister, Michael
    Dienemann, Hendrik
    Dyckhoff, Gerhard
    Herold-Mende, Christel
    Grummt, Ingrid
    Niehrs, Christof
    Plass, Christoph
    [J]. MOLECULAR CELL, 2014, 55 (04) : 604 - 614
  • [8] Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma
    Babar, Imran A.
    Cheng, Christopher J.
    Booth, Carmen J.
    Liang, Xianping
    Weidhaas, Joanne B.
    Saltzman, W. Mark
    Slack, Frank J.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (26) : E1695 - E1704
  • [9] Managing MicroRNAs with Vector-Encoded Decoy-Type Inhibitors
    Bak, Rasmus O.
    Hollensen, Anne Kruse
    Mikkelsen, Jacob Giehm
    [J]. MOLECULAR THERAPY, 2013, 21 (08) : 1478 - 1485
  • [10] Network biology:: Understanding the cell's functional organization
    Barabási, AL
    Oltvai, ZN
    [J]. NATURE REVIEWS GENETICS, 2004, 5 (02) : 101 - U15